Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Antiplatelet agents from Taisho

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Bristol-Myers Squibb to develop Toray antiplatelet agent in the U.S. and Canada

Oct. 11, 1996

Fujisawa's antiplatelet agent in clinical trials

Oct. 11, 1996

Integrin receptor antagonists described by SKB

Oct. 11, 1996

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Fibrinogen antagonist research continues at Merck & Co.

Oct. 11, 1996

BB-10153 development progresses

Oct. 4, 1996

Fibrinogen antagonists reported by Searle

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...